Home Blog

Stories from BTNX

Medetomidine Test Strip: The Leading Strip on the Market

The Rapid Response Medetomidine Test Strip from BTNX has been developed for efficient screening of Medetomidin...

Celebrating 25 Years of Innovation, Service, and Impact

News & Announcements

Why Remote Proctoring is a Game-Changer: The Future of Drug Testing for Healthcare and the Modern Workforce

Since the pandemic, increased telehealth use has led to greater interest in remote drug testing. Drug testing ...

Fentanyl Test Strip Product Improvement

Fentanyl is a highly potent, synthetic opioid related to the phenylpiperidines.1, 5 Fentanyl is approximately ...

Join BTNX at the Women in Safety Summit in Calgary!

We are thrilled to announce that BTNX will be attending the Women in Safety Summit in Calgary as a proud partn...

New Rapid Response® Medetomidine Test Strip

Since 2022, Medetomidine has been identified as a new illicit substance in the drug market. The Rapid Response...

Product Highlight - Nitazene Test Strip

Nitazenes are a class of synthetic drugs that have gained attention in the United States and other countries i...

Bars, Nightclubs, and Restaurants Now Required by Law to Provide Drink Testing Devices in California

New law measure aimed at enhancing safety and prevention in establishments that serve alcohol, allowing patron...

Empowering Safer Choices: Positive Impacts of Drug Checking Test Strips, as Highlighted by Public Health Ontario

In the ongoing effort to mitigate the risks associated with ...

PatientVu Now Integrated with Rapid Response Drug Screen Scanner

PatientVu users can now automatically transfer results data from the Rapid Response Lateral Flow Scanner into ...